Xiao Hui Ji
Direktor/Vorstandsmitglied bei LEGEND BIOTECH CORPORATION
Vermögen: 430 341 $ am 30.04.2024
Aktive Positionen von Xiao Hui Ji
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LEGEND BIOTECH CORPORATION | Direktor/Vorstandsmitglied | 01.05.2020 | - |
Independent Dir/Board Member | - | - | |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Vorsitzender | 01.01.2017 | - |
Vorstandsvorsitzender | 01.01.2017 | - | |
Gründer | 01.01.2017 | - | |
Direktor/Vorstandsmitglied | 01.01.2017 | - |
Karriereverlauf von Xiao Hui Ji
Ehemalige bekannte Positionen von Xiao Hui Ji
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 01.01.2017 | 01.05.2020 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01.01.2013 | 01.12.2016 |
The BayHelix Group | Direktor/Vorstandsmitglied | 01.01.2008 | 01.01.2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Vorstandsvorsitzender | - | 01.01.2012 |
Ausbildung von Xiao Hui Ji
China Medical University | Graduate Degree |
The University of Sheffield | Graduate Degree |
The University of Chicago | Masters Business Admin |
Statistik
International
China | 5 |
Vereinigte Staaten | 4 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
LEGEND BIOTECH CORPORATION | Health Technology |
ROCHE HOLDING AG | Health Technology |
Private Unternehmen | 4 |
---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
The BayHelix Group | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
- Börse
- Insiders
- Xiao Hui Ji
- Erfahrung